Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Wafik El-Deiry
Research Inst of Fox Chase Can Ctr, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Research Institute of Fox Chase Cancer Center
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
For each SFI, the compound studied in the project is licensed to an entity that is providing equity and a royalty stream to Dr. El-Deiry.
TIC10 anti-tumor effect through regulation of Foxo3a and TRAIL
We have discovered a new drug called TIC10 that uses normal and cancer cells to make a substance in your body called TRAIL that kills cancer cells. These studies will help understand how TIC10 works, will identify how key molecules are changed by TIC10, and see if similar changes are seen in actual tumors of patients. This work will help greatly to advance TIC10 to the clinic in the future.
Filed on March 23, 2015.
Tell us what you know about Wafik El-Deiry's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Wafik El-Deiry filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Wafik El-Deiry | Research Inst of Fox Chase Can Ctr | Conflict of Interest | Research Institute of Fox Chase Cancer Center | Value cannot be readily determined |
Wafik El-Deiry | Brown University | Conflict of Interest | Oncoceutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.